Urologix Inc. (ULGX)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

14405 21ST AVE N MINNEAPOLIS, MN 55447

Urologix Inc. offers non-surgical, catheter-based therapies that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia, a disease that affects more than 23 million men worldwide. The company markets its products under the Targis and Prostatron names.

View SEC Filings from ULGX instead.

View recent insider trading info

Funds Holding ULGX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ULGX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MADSON SCOTT M. CHIEF FINANCIAL OFFICER

  • Officer
0 2015-04-01 0

EMERY SIDNEY W JR

  • Director
235,278 2014-11-19 0

DANN MITCHELL

  • Director
602,388 2014-11-06 0

SPANGLER PATRICK D

  • Director
155,257 2014-11-06 0

BARYS CHRISTOPHER R

  • Director
155,257 2014-11-06 0

FLUET GREGORY CEO

  • Officer
  • Director
289,374 2014-08-13 0

ACKERMANN LISA A EVP, SALES AND MARKETING

  • Officer
139,132 2014-08-13 0

SMRDEL BRIAN J CHIEF FINANCIAL OFFICER

  • Officer
15,000 2013-08-14 0

WARREN STRYKER JR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
457,280 2012-06-29 0

CARDINAL RALPH PETER VP RESEARCH & DEVELOPMENT

  • Officer
10,000 2011-09-09 0

MOORE WILLIAM M

  • Director
79,154 2009-11-16 0

JACKSON GUY C.

  • Director
16,774 2009-11-10 0

WEBER REBECCA J DIR. OF FINANCE & CONTROLLER

  • Officer
0 2009-08-06 0

STARKS DANIEL J

  • Director
30,000 2008-11-11 0

CIRINO JERRY C

  • Director
0 2008-11-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments